Literature DB >> 12217251

Evolving strategies for the use of combination therapy in hypertension.

Alan H Gradman1, Celso Acevedo.   

Abstract

Two thirds of patients with hypertension require more than one drug to achieve goal blood pressure. Rational antihypertensive drug combinations are based on their ability to produce additive blood pressure reduction and reduce the incidence of dose-dependent side effects. Some combinations exhibit side-effect neutralization in which side effects associated with one drug are neutralized by a second agent. Fixed-dose combinations improve adherence by reducing the number of pills and simplifying the treatment regimen. Because volume overload is common, low-dose diuretics are often included in drug combinations. Combinations of diuretics with potassium-sparing diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and b-blockers are useful in treating large segments of the hypertensive population. Combinations of calcium channel blockers and angiotensin converting enzyme inhibitors are also effective and reduce the incidence of calcium blocker-related edema. Combinations of agents affecting the renin-angiotensin system by different mechanisms are currently the subject of active investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217251     DOI: 10.1007/s11906-002-0062-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  18 in total

1.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session.

Authors:  Eric S Williams; John M Miller
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.

Authors:  A H Gradman; N R Cutler; P J Davis; J A Robbins; R J Weiss; B C Wood
Journal:  Am J Cardiol       Date:  1997-02-15       Impact factor: 2.778

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.

Authors:  C E Mogensen; S Neldam; I Tikkanen; S Oren; R Viskoper; R W Watts; M E Cooper
Journal:  BMJ       Date:  2000-12-09

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  Diuretic therapy for hypertension and the risk of primary cardiac arrest.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; K G Wicklund; X Lin; L Cobb; P M Rautaharju; M K Copass; E H Wagner
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

9.  Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents.

Authors: 
Journal:  Arch Intern Med       Date:  1984-10

10.  Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Authors:  G L Bakris; M R Weir; V DeQuattro; F G McMahon
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

View more
  12 in total

Review 1.  Fixed drug combinations for the acute treatment of migraine : place in therapy.

Authors:  Elizabeth Loder
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Effects of oral fixed-dose combinations of telmisartan plus ramipril and losartan plus ramipril in hypertension: A multicenter, prospective, randomized, double-blind, phase iii trial in adult indian patients.

Authors:  S D Jain; Sangram Biradar; I Periyandavar; Sanjeet Singh Sodhi; K Anwaruddin; Ashish Gawde; Vidyagauri Baliga; Kailas Gandewar; Anish Desai
Journal:  Curr Ther Res Clin Exp       Date:  2005-11

Review 3.  Hydrochlorothiazide versus calcium channel blockers: what is the best add-on to a renin-angiotensin system blocker for treating hypertension in patients with renal disease?

Authors:  Edgar V Lerma
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

Review 4.  Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus.

Authors:  Mark A Munger
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

5.  Delapril/manidipine.

Authors:  Paul L McCormack; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.

Authors:  Maurizio Destro; Francesca Cagnoni; Antonio D'Ospina; Alessandra Rossi Ricci; Elena Demichele; Emmanouil Peros; Augusto Zaninelli; Paola Preti
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

7.  Combination therapy in hypertension.

Authors:  Alan H Gradman; Jan N Basile; Barry L Carter; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-10       Impact factor: 3.738

8.  A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  Integr Blood Press Control       Date:  2011-01-19

9.  Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches.

Authors:  George L Bakris; Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738

10.  A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285].

Authors:  Cornel Pater; Deepak Bhatnagar; Jean-Pascal Berrou; Joachim Luszick; Katrin Beckmann
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.